Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator (English)
- New search for: Williams, Daphne
- New search for: Tao, Xiaolu
- New search for: Zhu, Lili
- New search for: Stonier, Michele
- New search for: Lutz, Justin D.
- New search for: Masson, Eric
- New search for: Zhang, Sean
- New search for: Ganguly, Bishu
- New search for: Tzogas, Zoe
- New search for: Lubin, Susan
- New search for: Murthy, Bindu
- New search for: Williams, Daphne
- New search for: Tao, Xiaolu
- New search for: Zhu, Lili
- New search for: Stonier, Michele
- New search for: Lutz, Justin D.
- New search for: Masson, Eric
- New search for: Zhang, Sean
- New search for: Ganguly, Bishu
- New search for: Tzogas, Zoe
- New search for: Lubin, Susan
- New search for: Murthy, Bindu
In:
British Journal of Clinical Pharmacology
;
83
, 2
;
370-380
;
2017
- Article (Journal) / Electronic Resource
-
Title:Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator
-
Contributors:Williams, Daphne ( author ) / Tao, Xiaolu ( author ) / Zhu, Lili ( author ) / Stonier, Michele ( author ) / Lutz, Justin D. ( author ) / Masson, Eric ( author ) / Zhang, Sean ( author ) / Ganguly, Bishu ( author ) / Tzogas, Zoe ( author ) / Lubin, Susan ( author )
-
Published in:British Journal of Clinical Pharmacology ; 83, 2 ; 370-380
-
Publisher:
-
Publication date:2017-02-01
-
Size:11 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 83, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 217
-
Issue Information| 2017
- 219
-
Issue highlights| 2017
- 221
-
Composite endpoints and the distortion of risk–benefit analysisWarren, John B. et al. | 2017
- 224
-
Poor reporting and documentation in drug‐associated Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis – Lessons for medication safetyGoldblatt, Caitlin / Khumra, Sharmila / Booth, Jane / Urbancic, Karen / Grayson, M. Lindsay / Trubiano, Jason A. et al. | 2017
- 227
-
The value of patient reporting to the pharmacovigilance system: a systematic reviewInácio, Pedro / Cavaco, Afonso / Airaksinen, Marja et al. | 2017
- 247
-
Understanding and applying pharmacometric modelling and simulation in clinical practice and researchStanding, Joseph F. et al. | 2017
- 255
-
Microtubule destabilising agents: far more than just antimitotic anticancer drugsBates, Darcy / Eastman, Alan et al. | 2017
- 269
-
Managing drug–drug interactions with new direct‐acting antiviral agents in chronic hepatitis CTalavera Pons, Sarah / Boyer, Anne / Lamblin, Geraldine / Chennell, Philip / Châtenet, François‐Thibault / Nicolas, Carine / Sautou, Valérie / Abergel, Armand et al. | 2017
- 294
-
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patientsKuip, Evelien J. M. / Zandvliet, Maarten L. / Koolen, Stijn L. W. / Mathijssen, Ron H. J. / van der Rijt, Carin C. D. et al. | 2017
- 314
-
Population pharmacokinetics and analgesic potency of oxycodoneChoi, Byung‐Moon / Lee, Yong‐Hun / An, Sang‐Mee / Lee, Soo‐Han / Lee, Eun‐Kyung / Noh, Gyu‐Jeong et al. | 2017
- 326
-
Pharmacokinetics and pharmacodynamics of PF‐05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjectsDenney, William S. / Sonnenberg, Gabriele E. / Carvajal‐Gonzalez, Santos / Tuthill, Theresa / Jackson, V. Margaret et al. | 2017
- 339
-
Thorough QT study of the effect of intravenous amisulpride on QTc interval in Caucasian and Japanese healthy subjectsTäubel, Jörg / Ferber, Georg / Fox, Gabriel / Fernandes, Sara / Lorch, Ulrike / Camm, A. John et al. | 2017
- 349
-
Translating QT interval prolongation from conscious dogs to humansDubois, Vincent F. S. / Smania, Giovanni / Yu, Huixin / Graf, Ramona / Chain, Anne S. Y. / Danhof, Meindert / Della Pasqua, Oscar / on behalf of the Cardiovascular Safety Project Team / TI Pharma PKPD Platform et al. | 2017
- 363
-
Altered pharmacodynamics and pharmacokinetics of cisatracurium in patients with severe mitral valve regurgitation during anaesthetic induction periodLiu, Jiayi / Lu, Chunying / Zou, Qirong / Wang, Sheng / Peng, Xuemei et al. | 2017
- 370
-
Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulatorWilliams, Daphne / Tao, Xiaolu / Zhu, Lili / Stonier, Michele / Lutz, Justin D. / Masson, Eric / Zhang, Sean / Ganguly, Bishu / Tzogas, Zoe / Lubin, Susan et al. | 2017
- 381
-
An S‐warfarin and AZD1981 interaction: in vitro and clinical pilot data suggest the N‐deacetylated amino acid metabolite as the primary perpetratorGrime, Ken / Pehrson, Rikard / Nordell, Pär / Gillen, Michael / Kühn, Wolfgang / Mant, Timothy / Brännström, Marie / Svanberg, Petter / Jones, Barry / Brealey, Clive et al. | 2017
- 393
-
An assessment of the variation in the concentration of acetylcysteine in infusions for the treatment of paracetamol overdoseBailey, George P. / Wood, David M. / Archer, John R. H. / Rab, Edmund / Flanagan, Robert J. / Dargan, Paul I. et al. | 2017
- 400
-
Eosinophilic drug reactions detected by a prospective pharmacovigilance programme in a tertiary hospitalRamírez, Elena / Medrano‐Casique, Nicolás / Tong, Hoi Y. / Bellón, Teresa / Cabañas, Rosario / Fiandor, Ana / González‐Ramos, Jessica / Herranz, Pedro / Trigo, Elena / Muñoz, Mario et al. | 2017
- 416
-
The impact of serious adverse drug reactions: a population‐based study of a decade of hospital admissions in New South Wales, AustraliaWalter, Scott R. / Day, Richard O. / Gallego, Blanca / Westbrook, Johanna I. et al. | 2017
- 427
-
Chemical gastritis and colitis related to hydrogen peroxide mouthwashZanelli, Magda / Ragazzi, Moira / De Marco, Loredana et al. | 2017
- 429
-
Contraindicated use of 5‐alpha‐reductase inhibitors in womenTeichert, Martina / van Puijenbroek, Eugene / Stricker, Bruno H. et al. | 2017
- 432
-
Endpoints in strategies to reduce polypharmacyGaviria‐Mendoza, Andrés / Machado‐Alba, Jorge Enrique / Castaño‐Montoya, Juan Pablo / Machado‐Duque, Manuel Enrique / Giraldo‐Giraldo, Claudia et al. | 2017
- 434
-
Reply to ‘Endpoints in strategies to reduce polypharmacy’Johansson, Tim / Flamm, Maria / Sönnichsen, Andreas et al. | 2017
- 435
-
Discrepancies in paper by Chiam et al.: The haemodynamic effects of intravenous paracetamolWestergren, Tone / Debernard, Karen Astrid Boldingh et al. | 2017
- 436
-
Erratum| 2017